phenylacetylglutamine has been researched along with Renal Insufficiency, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| de Loor, H; Ebert, T; Evenepoel, P; Hobson, S; Kublickiene, K; Qureshi, AR; Ripswedan, J; Söderberg, M; Stenvinkel, P; Wennberg, L | 1 |
| Lee, S; Mair, RD; Meyer, TW; Plummer, NS; Sirich, TL | 1 |
| Augustijns, P; Claes, K; de Loor, H; Evenepoel, P; Kuypers, D; Meijers, B; Poesen, R | 1 |
3 other study(ies) available for phenylacetylglutamine and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Phenylacetylglutamine and trimethylamine N-oxide: Two uremic players, different actions.
Topics: Calcium; Cross-Sectional Studies; Humans; Phosphates; Renal Insufficiency, Chronic; Vascular Calcification | 2023 |
Impaired Tubular Secretion of Organic Solutes in Advanced Chronic Kidney Disease.
Topics: Adult; Aged; Creatinine; Cresols; Female; Glomerular Filtration Rate; Glutamine; Hippurates; Humans; Indican; Kidney Tubules; Male; Metabolomics; Middle Aged; Renal Insufficiency, Chronic; Solubility; Uremic Toxins | 2021 |
Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Glutamine; Humans; Male; Microbiota; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic | 2016 |